Tourette Syndrome Clinical Trial
Official title:
Enhancing Physical Activity in Children With Tics and Tourette Syndrome: Impact on Tic Severity and Quality of Life
Verified date | August 2015 |
Source | Children's Hospital of Eastern Ontario |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Institutional Review Board |
Study type | Interventional |
Tics are brief repetitive movements or vocalizations. Gilles de la Tourette's syndrome (TS)
is a disorder characterized by recurrent motor and vocal tics. Tourette syndrome and tic
disorders affect up to 8% of children. Peak severity of tic disorders occurs between the
ages of 8 to 12 years, therefore during childhood and adolescence the most significant
impacts are felt. The quality of life of young people with tics is lower than their peers'
and tic severity predicts lower quality of life. Studies have also shown negative social
perception toward children with tics.
Approximately 50% of patients with Tourette syndrome will have other diagnoses including
attention deficit hyperactivity disorder (ADHD), obsessive compulsive disorder, anxiety and
depression. Studies have shown improvements in ADHD with physical activity. ADHD and tic
disorders are thought to involve the same areas of the brain; thus it is possible that tics
might also improve with physical activity. However, no studies to date have examined this.
The investigators predict that by implementing a motivational physical activity program, in
conjunction with physical activity counseling, the investigators will be able to increase
levels of physical activity in children with tics and Tourette syndrome, with a positive
impact on tic severity.
Status | Completed |
Enrollment | 14 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 8 Years to 16 Years |
Eligibility |
Inclusion Criteria: - Participants are between 8-16 years of age. - Participants are required to have a diagnosis of either Tourette Syndrome or Persistent (Chronic) Motor of Vocal Tic Disorder as per the DSM V. - Participants must be ambulatory. - Participants and parents must understand English or French. - Participants must be able and willing to complete the questionnaires. - Participants cannot have any changes to their medication for tics, or any other psychotropic medications for 4 weeks prior to and for the entire duration of the study Exclusion Criteria: - Participants who cannot ambulate independently. - Participants who are not permitted to participate in physical education class at school. - Participants or families who are not willing to be randomly assigned to a study group. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | Children's Hospital of Eastern Ontario | Ottawa | Ontario |
Lead Sponsor | Collaborator |
---|---|
Children's Hospital of Eastern Ontario |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in PedsQL 4.0 measure | 8 weeks | No | |
Other | Change in KidScreen-27 | 8 weeks | No | |
Other | Chang in The Children's Self-perceived Adequacy and Predilection for Physical Activity Questionnaire | 8 Weeks | No | |
Other | Change in step count via pedometer | 8 weeks | No | |
Primary | Decrease in Yale Global Tic Severity Scale. | 8 weeks | No | |
Secondary | Change in The Gilles de la Tourette Syndrome Quality of Life Scale for children and adolescents | 8 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04851678 -
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
|
||
Completed |
NCT02605902 -
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
|
N/A | |
Completed |
NCT04007913 -
Incorporating teleCBIT Into a Hospital-Based Tic Program
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02216474 -
Brain Stimulation in Movement Disorders
|
N/A | |
Completed |
NCT02256475 -
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01329198 -
Brain Stimulation for the Treatment of Tourette Syndrome
|
N/A | |
Terminated |
NCT00952601 -
Pilot Study of the Modified Atkins Diet for Tourette Syndrome
|
Phase 1 | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00206323 -
A Randomized, Placebo-controlled, Tourette Syndrome Study.
|
Phase 3 | |
Completed |
NCT00004376 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
|
Phase 3 | |
Completed |
NCT04498364 -
Extinction Learning in Adults With Tourette Syndrome
|
N/A | |
Completed |
NCT00755339 -
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
|
||
Completed |
NCT03325010 -
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT01719523 -
Open-Trial of EPI-743 for Adults With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01702077 -
Neurofeedback for Tourette Syndrome
|
N/A | |
Completed |
NCT00231985 -
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
|
Phase 2 | |
Completed |
NCT00206336 -
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
|
Phase 3 | |
Terminated |
NCT03732534 -
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
|
Phase 2 |